Methylphenidate hydrochloride
SIGMA/M2892
Synonym: threo-Methyl α-phenyl-α-(2-piperidyl)acetate hydrochloride; Ritalin hydrochloride
CAS Number: 298-59-9
Empirical Formula (Hill Notation): C14H19NO2 · HCl
Molecular Weight: 269.77
EC Number: 206-065-3
MDL Number: MFCD00058191
Linear Formula: C14H19NO2 · HCl
Product Type: Chemical
| application(s) | forensics and toxicology |
| description | Drug Control: Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet |
| drug control | USDEA Schedule II; Home Office Schedule 2; stupéfiant (France); kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIB (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet |
| InChI | 1S/C14H19NO2.ClH/c1-17-14 |
| InChI key | JUMYIBMBTDDLNG-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].COC(=O)C(C1CCCCN1)c |
| Biochem/physiol Actions: | CNS stimulant; releases catecholamines; potent inhibitor of dopamine reuptake |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 - H334 |
| Precautionary statements | P261 - P264 - P270 - P284 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22-42 |
| Safety Statements | 22-26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |



